Quantcast

Industry news that matters to you.  Learn more

Agendia Announces New Agreement with Daiichi Sankyo to Support Oncology Drug Development

Agendia recently announced a new agreement with Daiichi Sankyo regarding oncology drug development and personalized medicine. The agreement calls for Agendia’s oncology biomarker technology to be used in the assessment of novel pharmaceuticals now being researched in certain Daiichi Sankyo clinical trials.

Agendia Announces New Agreement with Daiichi Sankyo to Support Oncology Drug Development

Agendia recently announced a new agreement with Daiichi Sankyo regarding oncology drug development and personalized medicine. The agreement calls for Agendia’s oncology biomarker technology to be used in the assessment of novel pharmaceuticals now being researched in certain Daiichi Sankyo clinical trials.